Cargando…
Clinical outcomes after IL-6 blockade in patients with COVID-19 and HIV: a case series
BACKGROUND: In hospitalized people with HIV (PWH) there is an increased risk of mortality from COVID-19 among hospitalized PWH as compared to HIV-negative individuals. Evidence suggests that tocilizumab—a humanized monoclonal interleukin (IL)-6 receptor inhibitor (IL-6ri) antibody—has a modest morta...
Autores principales: | Minkove, Samuel J., Geiger, Grant, Llibre, Josep M., Montgomery, Mary W., West, Natalie E., Chida, Natasha M., Antar, Annukka A. R., Dandachi, Dima, Weld, Ethel D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832430/ https://www.ncbi.nlm.nih.gov/pubmed/35148782 http://dx.doi.org/10.1186/s12981-022-00430-x |
Ejemplares similares
-
961. Experience, Lessons, and Strategies in Developing a High-Impact Real-Time Learning Network for Clinicians Caring for Patients with COVID-19 Infection
por: Kullar, Ravina, et al.
Publicado: (2021) -
Pulmonary Infection in a Patient After Stem Cell Transplantation
por: Dandachi, Dima, et al.
Publicado: (2017) -
IL-10 Signaling Blockade Controls Murine West Nile Virus Infection
por: Bai, Fengwei, et al.
Publicado: (2009) -
Acute Streptococcus constellatus Pyogenic Liver Abscess Due to an Atypical Presentation of Sigmoid Diverticulitis Complicated by Pericolonic Abscess
por: Navarrete, Daniela, et al.
Publicado: (2020) -
Curing glioblastoma: oncolytic HSV-IL12 and checkpoint blockade
por: Saha, Dipongkor, et al.
Publicado: (2017)